All sponsors

Xuanzhu Biopharmaceutical Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-34
RECRUITING2
READOUTS ≤12 MONTHS1
Open Xuanzhu Biopharmaceutical Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
XZP-3287+Fulvestrant
NCT05077449
P3Active, not recruitingAdvanced Breast Cancer3002024-02-22
XZP-5955 tablets
NCT04996121
P1/2RecruitingLocally Advanced or Metastatic Solid Tumors; Locally Advanced or Metastatic Non-small Cell Lung Cancer3602025-09
XZP-3287+ Letrozole/Anastrozole
NCT05257395
P3Active, not recruitingAdvanced Breast Cancer3972025-12-05 (+12 mo)
NCT07010107
NCT07010107
P3RecruitingReflux Esophagitis (RE)5002026-04
Anaprazole Sodium enteric-coated tablet
NCT07606833
P3Not yet recruitingHELICOBACTER PYLORI INFECTIONS5562027-02-19